BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19010265)

  • 1. Induction chemotherapy in locally advanced head and neck cancer: a new standard of care?
    Lorch JH; Posner MR; Wirth LJ; Haddad RI
    Hematol Oncol Clin North Am; 2008 Dec; 22(6):1155-63, viii. PubMed ID: 19010265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer?
    Adelstein DJ; Leblanc M
    J Clin Oncol; 2006 Jun; 24(17):2624-8. PubMed ID: 16763275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy].
    Bardet E; Bourhis J; Cals L; Fayette J; Guigay J; Hans S; Saint-Guily JL; Lagarde F; Lallemant B; Milano G; Rolland F; Lefebvre JL
    Bull Cancer; 2009 Oct; 96(10):1013-28. PubMed ID: 19744919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradigm shift in the treatment of head and neck cancer: the role of neoadjuvant chemotherapy.
    Posner MR
    Oncologist; 2005; 10 Suppl 3():11-9. PubMed ID: 16368867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy in head and neck cancer: should it be revisited?
    Specenier PM; Vermorken JB
    Cancer Lett; 2007 Oct; 256(2):166-77. PubMed ID: 17673364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual patients' data meta-analyses in head and neck cancer.
    Bourhis J; Le Maître A; Baujat B; Audry H; Pignon JP; ; ;
    Curr Opin Oncol; 2007 May; 19(3):188-94. PubMed ID: 17414635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New options in the treatment of locally advanced head and neck cancer: role for induction chemotherapy.
    Cruz JJ; Ocaña A; Navarro M; Barco ED; Fonseca E
    Cancer Treat Rev; 2008 May; 34(3):268-74. PubMed ID: 18194842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review.
    Murdoch D
    Curr Opin Oncol; 2007 May; 19(3):216-21. PubMed ID: 17414639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy of cisplatin and fluorouracil regimen in head and neck squamous cell carcinoma: a meta-analysis.
    Su YX; Zheng JW; Zheng GS; Liao GQ; Zhang ZY
    Chin Med J (Engl); 2008 Oct; 121(19):1939-44. PubMed ID: 19080128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The present situation of neoadjuvant therapy for head and neck carcinoma].
    Rikimaru F; Tomita K
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1535-7. PubMed ID: 17940367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
    Kiyota N; Tahara M; Kadowaki S; Fuse N; Doi T; Minami H; Ohtsu A
    Jpn J Clin Oncol; 2009 Apr; 39(4):225-30. PubMed ID: 19211574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemotherapy: to use or not to use? That is the question.
    Brizel DM; Vokes EE
    Semin Radiat Oncol; 2009 Jan; 19(1):11-6. PubMed ID: 19028340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Induction chemotherapy for locally advanced head and neck cancer].
    Calais G; Chapet S; Ruffier-Loubière A; Bernadou G
    Cancer Radiother; 2013 Oct; 17(5-6):498-501. PubMed ID: 24011601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and emerging standards of concomitant chemoradiotherapy.
    Adelstein DJ; Rodriguez CP
    Semin Oncol; 2008 Jun; 35(3):211-20. PubMed ID: 18544436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the management of squamous cell carcinoma of the head and neck.
    Kim KB; Khuri FR; Shin DM
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):99-110. PubMed ID: 12113140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status and future directions in induction chemotherapy for head and neck cancer.
    Argiris A
    Crit Rev Oncol Hematol; 2013 Oct; 88(1):57-74. PubMed ID: 23541071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiochemotherapy in locally advanced squamous cell carcinomas of the head and neck.
    Matzinger O; Zouhair A; Mirimanoff RO; Ozsahin M
    Clin Oncol (R Coll Radiol); 2009 Sep; 21(7):525-31. PubMed ID: 19535232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of clinical trials in head and neck cancer.
    Yang ES; Murphy BM; Chung CH; Netterville JL; Burkey BB; Gilbert J; Yarbrough WG; Sinard R; Cmelak AJ
    Crit Rev Oncol Hematol; 2009 Jul; 71(1):29-42. PubMed ID: 18996026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent chemotherapy and radiotherapy for head and neck cancer.
    Burri RJ; Lee NY
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):293-302. PubMed ID: 19275508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem cells in head and neck squamous cell cancer.
    Prince ME; Ailles LE
    J Clin Oncol; 2008 Jun; 26(17):2871-5. PubMed ID: 18539966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.